Utah Medical Products | UTMD - Cash And Equivalent


Utah Medical Products reported $84.27M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AngioDynamics USD 41.64M 14.26M Sep/2025
Baxter International USD 2.02B 51M Mar/2026
Cerus USD 19.96M 4.29M Dec/2025
CONMED USD 40.82M 1.89M Dec/2025
Cooper Companies USD 124.9M 14.3M Dec/2025
General Electric Aerospace USD 10.98B 1.41B Mar/2026
Integra LifeSciences USD 236.81M 1.76M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Merit Medical Systems USD 488.08M 41.68M Mar/2026
OraSure Technologies USD 176.96M 22.31M Mar/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Stryker USD 2.88B 1.13B Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Utah Medical Products USD 84.27M 2.09M Sep/2025
West Pharmaceutical Services USD 521.4M 269.9M Mar/2026